Cystic Fibrosis Functional Genomics
We contributed funding to the only laboratory in the southern hemisphere that offers a precision medicine platform using stem cell biology for children with cystic fibrosis.
This precision medicine platform predicts whether children (and adults) will respond well to new therapies, or whether existing therapies can be repurposed for patients with rare mutations.
-
Lead Investigators
- Professor Adam Jaffe
Head, School of Women’s and Children’s Health, UNSW Sydney (Australia) - Dr Shafagh Waters
Lead Scientist, Australasian Centre for Personalised Cystic Fibrosis Medicine (ACPCFM), School of Women’s and Children’s Health, UNSW Sydney (Australia)
- Professor Adam Jaffe
-
- UNSW Sydney (Australia)
- Vertex Pharmaceutical
- Royal Price Alfred Hospital (Australia)
- Loxegen Pharmaceutical
- Biospecialist Ltd
- CF Australia
-
See Luminesce Alliance Publications – completed research – Cystic Fybrosis Functional Genomics